Inventor · disambiguated record
Paul J. Conlon
Also filed as: CONLON III PAUL J · CONLON PAUL · CONLON PAUL J
17 granted patents·4 pending applications·865 citations·filing 1984–2005
95Inventor score
Files withNEUROCRINE BIOSCIENCES INC11IMMUNEX CORP6STANFORD UNIVERSITY MEDICAL CT2NEUROCRINE BIOSCIENCES1
Top patents by PatentIndex Score
21 records- 0198US5078996AActivation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factorIMMUNEX CORP·Filed 1986·Granted Jan 7, 1992·233 cites·26 claims
- 0297US4703004ASynthesis of protein with an identification peptideIMMUNEX CORP·Filed 1984·Granted Oct 27, 1987·251 cites·6 claims
- 0388US4782137ASynthesis of protein with an identification peptide, and hybrid polypeptide incorporating sameIMMUNEX CORP·Filed 1987·Granted Nov 1, 1988·84 cites·8 claims
- 0482US5484887AHomogeneous interleukin 1IMMUNEX CORP·Filed 1984·Granted Jan 16, 1996·43 cites·12 claims
- 0580US6489299B2Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinSTANFORD UNIVERSITY MEDICAL CT·Filed 2001·Granted Dec 3, 2002·12 cites·4 claims
- 0680US4658018AProcess for producing homogeneous colony stimulating factorIMMUNEX CORP·Filed 1984·Granted Apr 14, 1987·36 cites·4 claims
- 0779US6197926B1Methods for treatment of diabetes using peptide analogues of insulinNEUROCRINE BIOSCIENCES·Filed 1999·Granted Mar 6, 2001·51 cites·2 claims
- 0879US5122459AGene encoding biologically active human interleukin 1IMMUNEX CORP·Filed 1989·Granted Jun 16, 1992·37 cites·11 claims
- 0977US6251396B1Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 1998·Granted Jun 26, 2001·46 cites·3 claims
- 1072US6933274B2Methods for treatment of diabetes using a peptide analogues of insulinNEUROCRINE BIOSCIENCES INC·Filed 2003·Granted Aug 23, 2005·1 cites·22 claims
- 1171US6740638B2Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2002·Granted May 25, 2004·3 cites·4 claims
- 1269US5948764AMethods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 1997·Granted Sep 7, 1999·32 cites·6 claims
- 1368US6379670B1Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Apr 30, 2002·16 cites·1 claims
- 1458US6329499B1Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 1994·Granted Dec 11, 2001·10 cites·8 claims
- 1557US2004214775A1Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 1656US2006040863A1Methods for treatment of diabetes using peptide analogues of insulinNEUROCRINE BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 1751US2002176866A1Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2002·Application pending·0 cites
- 1849US6562942B1Methods for treatment of diabetes using peptide analogues of insulinNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted May 13, 2003·4 cites·18 claims
- 1947US2002086976A1Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic proteinNEUROCRINE BIOSCIENCES INC·Filed 2001·Application pending·0 cites
- 2042US6369033B1Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic proteinSTANFORD UNIVERSITY MEDICAL CT·Filed 1997·Granted Apr 9, 2002·3 cites·10 claims
- 2133US5945401APeptide analogues of the 65KD isoform of human glutamic acid decarboxylase and uses thereofFiled 1995·Granted Aug 31, 1999·3 cites·28 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →